Stately Bio
Stately Bio develops next-generation regenerative medicines using a patented machine learning cell imaging platform that measures cell identity, behavior, and maturation from live, label-free imaging. Their technology enables real-time, non-destructive monitoring of cell states, forecasting future cell function, and optimizing experiments, transforming cell therapy discovery and manufacturing. They partner with leading institutions and companies to advance cell therapy innovation, focusing on stem cell-derived therapies for regenerative medicine. Their business model involves technology development and partnerships in biotech and cell therapy sectors.
Stately Bio
Stately Bio develops next-generation regenerative medicines using a patented machine learning cell imaging platform that measures cell identity, behavior, and maturation from live, label-free imaging. Their technology enables real-time, non-destructive monitoring of cell states, forecasting future cell function, and optimizing experiments, transforming cell therapy discovery and manufacturing. They partner with leading institutions and companies to advance cell therapy innovation, focusing on stem cell-derived therapies for regenerative medicine. Their business model involves technology development and partnerships in biotech and cell therapy sectors.